HUTCHMED (China) (HMDCF) Dividends payables (2019)

HUTCHMED (China) (HMDCF) reported Dividends payables of -$14.6 million for Q4 2019.

HUTCHMED (China) (HMDCF) Dividends payables (2019) Analysis & Trends

HUTCHMED (China) (HMDCF) has 1 years of Dividends payables data on file, last reported at -$14.6 million in Q4 2019.

  • Dividends payables for Q4 2019 came in at -$14.6 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was -$14.6 million (changed N/A YoY), and the FY2019 annual result was -$14.6 million, changed N/A from the prior year.
  • Dividends payables was little changed at -$14.6 million in Q4 2019 per HMDCF's latest filing.
  • Over five years, Dividends payables peaked at -$14.6 million in Q4 2019 and troughed at -$14.6 million in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 224.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 HUTCHMED (China) - - - -

Historic Data

Download Data
DateValue
Dec 31, 2019 -14.62 Mn